|
|
Premenstrual
Syndrome (PMS) |
| |
|
Overview |
|
|
Definition |
|
Premenstrual syndrome (PMS) is characterized by somatic and psychologic
symptoms that occur during the week before menses begins (luteal phase) and end
within a few days of the onset of bleeding (follicular phase). PMS symptoms do
not occur in prepubertal, postmenopausal, anovulatory (e.g., pregnant) women, or
women who have undergone oophorectomy. PMS may begin at any age and remits at
menopause. Approximately 75% of women experience PMS to some degree; 20% to 50%
find that symptoms disrupt their daily activities; and 3% to 5% are
incapacitated by the severity of symptoms. |

|
|
Etiology |
|
While associations between the menstrual cycle and changes in mood and
behavior have been made since antiquity, the physiologic and pathologic
determinants of PMS are not completely defined. Theories regarding etiology
include abnormalities of gonadal steroids (e.g., estrogen excess, progesterone
deficiency), hypoglycemia, vitamin B6 deficiency, abnormalities of
prostaglandin metabolism, excessive fluid retention, and endogenous opiate
peptide withdrawal. |

|
|
Risk Factors |
|
- History of depressive, mood, anxiety, or biopolar disorders
- History of postpartum depression or psychotic episodes
- History of dysmenorrhea
- Family history of depression or bipolar disorder
- High stress
- High consumption of caffeine, salt, chocolate, tobacco, and
alcohol
|

|
|
Signs and Symptoms |
|
Over 150 symptoms have been attributed to PMS. The most common are the
following.
- Abnormal bloating and weight gain
- Breast swelling and tenderness
- Mood swings involving crying spells, irritability, and persistent
anger
- Depression (e.g., feeling sad, hopeless, or suicidal) and anxiety
(e.g., feeling tense or "on edge")
- Fatigue often accompanied by sleep disorders (e.g., insomnia,
hypersomnia) and lethargy
- Skin disorders (e.g., oily skin, hirsutism, acne)
- Changes in appetite, including food cravings (e.g., carbohydrates,
chocolate) and overeating
- Sexual dysfunction (e.g., decreased or increased libido)
- Headaches, backaches, and cramps
- Inability to concentrate, loss of interest in usual activities, and
confusion
|

|
|
Differential
Diagnosis |
|
A differential diagnosis should be made for each major symptom; thus,
eliminating possibilities becomes a daunting endeavor. Possible psychiatric
disorders, especially depression and anxiety disorders, as well any underlying
medical disorders, must be ruled out. |

|
|
Diagnosis |
|
The Diagnostic and Statistical Manual of Mental Disorders, 4th edition
(DSM-IV) classifies PMS as late luteal-phase dysphoric disorder, specifying the
following four diagnostic criteria.
- A symptom complex consistent with PMS must be present in most
menstrual cycles for the past year.
- Symptoms must occur within the luteal phase of the menstrual cycle
(e.g., appearing a week prior to menses) and disappear at the beginning of the
follicular phase (e.g., within a few days of the onset of bleeding).
- Symptoms must cause significant disruption of occupational or social
functioning (e.g., marital discord).
- Symptoms must not be an exacerbation of symptoms of another disorder.
|

|
|
Physical Examination |
|
A detailed history of symptoms, paying particular attention to the occurrence
of these symptoms throughout the menstrual cycle, is imperative. Detailed family
and medical histories are also important. Full physical and gynecologic
examinations can rule out other medical conditions. Women must chart their
symptoms and their severity daily for one to two months on PMS calendars so that
the pattern of each symptom can be evaluated. A psychosocial evaluation may
indicate the need for a mental health professional. |

|
|
Laboratory Tests |
|
There are no laboratory or imaging studies to confirm a diagnosis of PMS;
however, laboratory and radiologic studies can evaluate the signs and symptoms.
- Papanicolauo smear
- Complete blood count
- Serum chemistry screen
- Fasting blood glucose determinations
- Thyroid studies
|

|
|
Pathology/Pathophysiology |
|
Progesterone and its metabolites, secreted in prodigious amounts in the
luteal phase, and their variable extrahepatic metabolism may be responsible for
PMS. Decreased synthesis during the luteal phase of serotonin, a CNS
neurotransmitter responsible for mood changes, suggests an important role of
this neuroendocrine mechanism. The actions of gamma-aminobutyric acid (GABA),
which suppresses brain function, can be manipulated by medications to improve
mood. |

|
|
Other Diagnostic
Procedures |
|
Minnesota Multiphasic Personality Inventory (MMPI) is often normal if
administered in the follicular phase of the menstrual cycle but abnormal during
the luteal phase in women with PMS. |

|
|
Treatment Options |
|
|
Treatment Strategy |
|
There is no consensus about treatment strategies. Simple interventions such
as exercise and dietary restrictions (e.g., avoid salt, caffeine, alcohol,
chocolate) are attempted first, as improvement may result. Stress reduction may
also result in relief of some symptoms. Drug therapy may be necessary for severe
symptoms. |

|
|
Drug Therapies |
|
- Potassium-sparing diuretics, for bloating and water
retention
- Analgesics, for headaches and cramps
- Beta-blockers and calcium-channel blockers, for prophylactic treatment
of migraine headaches
- Prostaglandin inhibitors (e.g., mefenamate, 100 mg every six hours),
for dysmenorrhea
- Spironolactone (100 mg one or two times a day for last 14 days of
cycle), for oily skin, hirsutism, and acne
- Anovulatory agents: danazol (200 to 400 mg/day); oral contraceptives
(e.g., 35 mcg estrogen-progestin or progestin only): side effects are common,
and oral contraceptives are contraindicated in women who are pregnant or have
breast cancer, abnormal uterine bleeding, or phlebitis; medroxyprogesterone
acetate (30 mg/day tablets): abnormal uterine bleeding is common, limiting its
usefulness; depomedroxyprogesterone acetate (150 mg intramuscularly every one to
three months).
- Bromocriptine (2.5 mg bid for last 14 days of cycle), for breast
soreness
- Anxiolytics agents (e.g., buspirone or alprazolam), for symptoms of
anxiety
- Tricyclic antidepressants (e.g., clomipramine, nortriptyline,
fluoxetine), for depression
- Progesterone—the most commonly requested
medicine (100 mg bid to tid), for relief of symptoms; however, progesterone does
not outperform placebo, and severe PMS symptoms have been noted at times of peak
progesterone levels.
|

|
|
Surgical Procedures |
|
Hysterectomy including oophorectomy with estrogen replacement therapy in PMS
patients whose symptoms are severe and refractory to
treatment. |

|
|
Complementary and Alternative
Therapies |
|
CAM therapies may be useful at decreasing intensity and duration of symptoms.
Nutritional deficiencies may be found in patients who suffer from PMS and should
be treated. Both herbs and homeopathy can be effective and may be prescribed
concurrently. Three months treatment is required before evaluating
effectiveness. |

|
|
Nutrition |
|
Avoid caffeine and saturated fats (both induce inflammatory prostaglandins
that exacerbate symptoms), sugar (increases urinary excretion of magnesium,
which is depleted in PMS sufferers), salt (fluid retention), and dairy, meat,
and poultry (to decrease exogenous hormones, and improve magnesium absorption).
Correct nutritional deficiencies by supplementation with the
following.
- Vitamin B6 (100 to 200 mg/day) with B-complex (50 to 100
mg/day)
- Magnesium (400 mg/day)
- Vitamin E (400 to 600 IU/day), especially with breast
tenderness
- Essential fatty acids: omega-3 and omega-6 (3,000 to 4,000 mg/day for
three months, then decrease dose by 1,000 mg every two months)
- Chromium (250 mcg one to two times/day) to reduce sugar
cravings
|

|
|
Herbs |
|
Herbs may be used as dried extracts (pills, capsules, or tablets), teas, or
tinctures (alcohol extraction, unless otherwise noted). Dose for teas is 1
heaping tsp. herb/cup water steeped for 10 minutes (roots need 20 minutes). For
PMS, teas or tinctures are preferred; however, dried extract dosages are also
included.
- Chaste tree (Vitex agnus castus) for PMS with irregular menses
(175 mg/day)
- Black cohosh (Cimicifuga racemosa) binds to estrogen receptors
to balance hormones, especially with dysmenorrhea and/or mood changes (100 to
600 mg/day).
- Valerian (Valeriana officinalis) for PMS with insomnia and
anxiety (150 to 300 mg one to four times/day, or before bed for insomnia); kava
kava (Piper methysticum) can be used for the same purpose (200 mg one to
four times/day, or before bed). Reduce dose of either herb if drowsiness
occurs.
- Milk thistle (Silybum marianum) supports liver in conjugating
estrogens (200 to 600 mg/day)
Use the above herbs in combination, either as tincture (60 drops tid) or tea
(1 cup bid to tid).
- Dandelion (Taraxacum officinale) root and/or leaves as a tea or
tincture are diuretics, historic use as a liver tonic. With biliary problems,
consult with an experienced practitioner.
- St. John's wort (Hypericum perforatum) (300 mg bid to tid) for
depression associated with PMS. Must be taken consistently throughout the month;
direct sun exposure may cause rashes in some
patients.
|

|
|
Homeopathy |
|
An experienced homeopath would consider an individual's constitutional type
to prescribe a more specific remedy and potency. Some of the most common acute
remedies are listed below. Acute dose is three to five pellets of 12X to 30C
every one to four hours until symptoms resolve.
- Belladonna for dysmenorrhea with profuse bright red bleeding,
especially with restlessness
- Chamomilla for dark clotted blood with labor-like pains, great
irritability, and restlessness
- Borax for irritability, headaches, and sleeplessness
- Calcarea carbonica for early, profuse, and long-term bleeding,
swollen and painful breasts, poor stamina
- Kreosotum for irritability, headache, nausea, and severe
vaginitis
- Nux vomica for extreme irritability, sharp cramping pain,
cravings for alcohol, coffee, and spicy foods
- Pulsatilla for painful irregular periods with headaches and
weepiness
- Sepia for painful, scanty menses with irritability and an
aversion to sex
|

|
|
Acupuncture |
|
Acupuncture is helpful in balancing hormones and reducing symptoms of PMS,
including anxiety, depression, insomnia, cramping, and
fatigue. |

|
|
Patient Monitoring |
|
Ongoing follow-up and periodic evaluations are imperative.
|

|
|
Other
Considerations |
|
|
Prevention |
|
Women with PMS who make lifestyle changes around menstruation such as
reducing stress, increasing exercise, and making dietary changes can often
prevent exacerbations of PMS symptoms. Medications and psychotherapy may be
useful in more severe cases. |

|
|
Complications/Sequelae |
|
Severe symptoms of PMS can disrupt relationships with family members,
friends, and colleagues at work. Some drug regimens can have serious and
debilitating side effects. A diagnosis of PMS can mask serious psychological
disorders. |

|
|
Prognosis |
|
The prognosis of PMS is variable but can be excellent with proper education
and individualized treatment modalities. At times, it may be important to
involve the family, especially the spouse, in this process. |

|
|
Pregnancy |
|
All symptoms of PMS disappear during pregnancy; however, approximately 68% of
women report that symptoms of PMS worsen after pregnancy. Women who are trying
to conceive should avoid prostaglandin inhibitors, diuretics, spironolactone,
and danazol. |

|
|
References |
|
American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association;
1994:715-718.
Balch JF, Balch PA. Prescription for Nutritional Healing. 2nd ed.
Garden City, NY: Avery Publishing; 1997:443-445.
Bartram T. Encyclopedia of Herbal Medicine. Dorset, England: Grace
Publishers; 1995:352.
Beck WW. Obstetrics and Gynecology. 2nd ed. New York, NY: John Wiley;
1989: 216.
Blumenthal M, ed. The Complete German Commission E Monographs. Boston,
Mass: Integrative Medicine Communications; 1998:119-20, 108, 90, 226-7.
Bowman MA. Ambulatory Care for the Adult. Madison, Conn: Fence Creek
Publishing; 1998:121, 139, 140, 438.
Cunningham FG, et al. Williams Obstetrics. 19th ed, Norwalk, Conn:
Appleton & Lange; 1993:97-99.
Danforth's Obstetrics and Gynecology. 7th ed. Philadelphia, Pa: J. B.
Lippincott; 1994:599-600, 677-678.
Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles
of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:290.
Gruenwald J, Brendler T, Jaenicke C, et al, eds. PDR for Herbal
Medicines. Montvale, NJ: Medical Economics Company; 1998:1222-3, 1175,
7476-8, 1204-6.
Keye WR Jr. The Premenstrual Syndrome. Philadelphia, PA: W. B.
Saunders; 1988: 48, 55, 62, 74, 78, 114-118, 120, 147-149, 151-152, 180-183.
Kruzel T. The Homeopathic Emergency Guide. Berkeley, Calif: North
Atlantic Books; 1992:112-118.
Morrison R. Desktop Guide to Keynotes and Confirmatory Symptoms.
Albany, Calif: Hahnemann Clinic Publishing; 1993:58-62, 68-9, 82-6, 210-1,
274-6, 310-5, 343-7.
Murray MT, Pizzorno JE. Encyclopedia of Natural Medicine. Rocklin,
Calif: Prima Publishing; 1998:470-479.
Rivlin ME, Martin RW. Manual of Clinical Problems in Obstetrics and
Gynecology. 4th ed. Boston, Mass: Little, Brown; 1994:401-404.
Werbach M. Nutritional Influences on Illness. New Canaan, Conn: Keats
Publishing Inc; 1987:364-369. |

|
Copyright © 2000 Integrative Medicine
Communications This publication contains
information relating to general principles
of medical care that should not in any event be construed as specific
instructions for individual patients. The publisher does not accept any
responsibility for the accuracy of the information or the consequences arising
from the application, use, or misuse of any of the information contained herein,
including any injury and/or damage to any person or property as a matter of
product liability, negligence, or otherwise. No warranty, expressed or implied,
is made in regard to the contents of this material. No claims or endorsements
are made for any drugs or compounds currently marketed or in investigative use.
The reader is advised to check product information (including package inserts)
for changes and new information regarding dosage, precautions, warnings,
interactions, and contraindications before administering any drug, herb, or
supplement discussed herein. | |